Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model

Cihangir Mutlu Ercan, Oya Kayaalp, Mehmet Cengiz, Mehmet Ali Cengiz, Ugur Keskin, Uğur Keskin, Nihat Yumusak, Nıhat Yumuşak, Ümit Aydoğan, Umit Aydogan, Tayfun Ide, Ali Ergün, Ali Ergun
Archives of gynecology and obstetrics · 2014 · vol. 291(5) , pp. 1103–1111 · doi:10.1007/s00404-014-3524-x · PMID:25367601 · W2068165479
article OA: closed CC0 ⤵ 29 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06+body, 2026-06-08 ⓘ

This study compared the efficacy of bromocriptine and cabergoline to leuprolide acetate in reducing endometriotic implants in a rat model, finding all treatments decreased implant size and histopathology scores versus controls.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents Bromocriptine Dopamine Agonists Endometriosis Endometrium Ergolines Leuprolide Adult Animals Antineoplastic Agents Antineoplastic Agents Bromocriptine Bromocriptine Cabergoline Disease Models, Animal Dopamine Agonists Dopamine Agonists Endometriosis Endometriosis Endometrium

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Cited by (29)

Source provenance

europepmc
last seen: 2026-07-04T06:08:07.471253+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:10.358439+00:00
License: CC0 · commercial use OK